They’re proposing a share buyback. Looks like this stock is going to fly

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3592187

Great! Alpha is back at the 30-cent level and is gradually showing an uptrend

ALPHA’s revenue increased by around 40%, climbing from RM125.99 million in FY 2024 to RM176.84 million in FY 2025. If it keeps growing like this, it could even break the RM200 million mark in FY 2026!

Alpha IVF & Women’s Specialists Launches International Patient Lounge to Strengthen Medical Tourism; Partners with Innoquest to Establish Malaysia’s First In-House Diagnostic Lab in a Stand-Alone IVF Centre

The global in vitro fertilization (IVF) market was worth about USD 26.2 billion in 2024. According to IMARC Group, it’s expected to almost double and hit around USD 50.9 billion by 2033, growing steadily at about 7.3% a year

In case you missed it, Alpha IVF made another big move last month on August 25th. They launched their first in-house pathology lab

Alpha IVF expects its Indonesia-based satellite clinics, including those in Jakarta and Surabaya, to make a meaningful contribution to cross-border patient volume and revenue growth.

Cambodia will also become a potential customer of Alpha IVF

https://www.businesstoday.com.my/2025/08/22/malaysia-strengthens-medical-tourism-outreach-with-cambodia-engagements/

long wait games

ALPHA intends to maintain a minimum 60% dividend payout, which translating into forecast yields of 3.4%-4.7% over FY26-FY28